Tobacco stocks gained slightly on Thursday after the FDA has authorized the marketing of 20 Zyn nicotine pouch products ...
Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit cigarettes.
Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned ...
Zyn products will be allowed to stay on the market after federal health officials Thursday said the popular nicotine pouches ...
The FDA gave marketing authorization to 20 different Zyn products, the most popular nicotine pouch product in the U.S.
The increasingly popular nicotine pouches pose a lower risk of cancer than cigarettes, U.S. health officials said.